In conclusion, based on four GEO transcriptome profiles, we identified 24,430 genes that were differential expression in osteosarcoma comparing to normal control samples, and further series of bioinformatic analysis of the genes highlight STC2 as a valuable prognostic indicator in cancer development. This evidence concerns the gene STC2 and osteosarcoma.